Back to search
Mitral Valve (MV) Regurgitation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mitral Valve (MV) Regurgitation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Mitral Valve (MV) Regurgitation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitra…
The objective of this study is to evaluate and predict the progression of moderate cardiac valve stenosis and regurgitation using clinical, biological, echocard…
Multicenter observational study. The study does not involve any interventions in routine clinical practice, the choice of treatment method (including the type o…
The surgical treatment of less than severe (≤2+/4+) functional tricuspid regurgitation (TR) in patient undergoing mitral valve surgery, is still controversial:…
CABA-MiTRA-AFNET12 is a non-commercial, parallel-group, prospective, randomised, open, blinded endpoint assessment (PROBE), multi-centre, therapy strategy trial…
To confirm the effectiveness and safety of the DragonFly M2 Transcatheter Mitral Valve Repair System for the treatment of symptomatic moderate-to-severe (3+) or…